Stocks-HCAT-Health Catalyst Inc

HCAT Health Catalyst Inc

14.55 -0.21 (-1.42%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest

Overview

Prev Close14.55
Day's Range 14.39 - 14.93
52 Week Range 6.39 - 30.99
Average Volume (3M)797.02K
1-Year Return-48.85%
Beta1.1991
Market Cap796.63M
P/E Ratio
Revenue271.79M
EPS-2.9418
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.722/08/202202/11/202217/01/20237.5010.0012.5015.0017.5020.00
Chart times in UTC
Industry Packaged Software
CEO Daniel D. Burton, MBA
Employees 1,200

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Health Catalyst Inc's revenues increased by 28.11% and amounted to 241.93M. Net income decreased by 33.21% to -153.21M. Net assets increased by 89.10% to 522.10M and EPS decreased from -2.91 to -3.23.
HCAT's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
31.75%
Net Profit Margin
-54.52%
Operating Margin
-49.19%
Return On Investment
-44.09%
12/21
03/22
06/22
09/22
Total Revenue
64.72M
68.09M
70.63M
68.35M
Gross Profit
20.01M
22.77M
23.65M
19.86M
Operating Income
-33.62M
-29.1M
-28.55M
-42.43M
Net Income
-48.99M
-22.46M
-33.43M
-45.74M